This topic contains a solution. Click here to go to the answer

Author Question: How do you calculate effect size for a Pearson product-moment correlation coefficient? A) ... (Read 27 times)

tatyanajohnson

  • Hero Member
  • *****
  • Posts: 569
How do you calculate effect size for a Pearson product-moment correlation coefficient?
 
  A) multiply the correlation coefficient by 2
  B) divide the correlation coefficient by the degrees of freedom
  C) square the correlation coefficient
  D) take the square root of the correlation coefficient

Question 2

Suppose you tested the effects of a drug on rats' learning by giving them 0, 5, 10, or 15
  milligrams of the drug. How many IVs do you have?
 
  A) 1 B) 2 C) 3 D) 4



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rachel

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

C

Answer to Question 2

A




tatyanajohnson

  • Member
  • Posts: 569
Reply 2 on: Jun 20, 2018
:D TYSM


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library